Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
TAMPA, FL, MAY 29, 2019 – HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to...
TAMPA, FL, MAY 6, 2019 – HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), a pharmaceutical development company focused on discovering, developing and ultimately commercializing innovative...
Tampa, FL, April 15, 2019 – HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a pharmaceutical development company focused on discovering, developing and ultimately commercializing innovative...
Corporate Highlights: Secured the potential for up to $5 million in new funding ($1.5 million of which has been funded to date) and further secured a 9% royalty on future U.S. sales of...
FOR IMMEDIATE RELEASE -- TAMPA, FLORIDA (December 17, 2018) – HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) announced today that it has entered into a revised Supply and License Agreement (SLA)...